Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: lapatinib
Sponsor: University of Kansas Medical Center